<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01792336</url>
  </required_header>
  <id_info>
    <org_study_id>130076</org_study_id>
    <secondary_id>13-N-0076</secondary_id>
    <nct_id>NCT01792336</nct_id>
  </id_info>
  <brief_title>Transcranial Magnetic Stimulation for Focal Hand Dystonia</brief_title>
  <official_title>Gamma Frequency Transcranial Magnetic Stimulation in Dystonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      Background:&#xD;
&#xD;
        -  The brain has natural electrical rhythms of brain activities. These rhythms may be&#xD;
           different in people with movement disorders, such as dystonia (involuntary muscle&#xD;
           movement, cramps, or tremors). Understanding these rhythms may provide more information&#xD;
           about movement disorders.&#xD;
&#xD;
        -  Focal hand dystonia, also known as &quot;writer's cramp&quot; or &quot;musician's cramp,&quot; is a painful&#xD;
           condition that affects the hand and arm muscles. Researchers want to use transcranial&#xD;
           magnetic stimulation (TMS) to study brain rhythms in people with and without focal hand&#xD;
           dystonia.&#xD;
&#xD;
      Objectives:&#xD;
&#xD;
      - To better understand brain rhythms involved in focal hand dystonia.&#xD;
&#xD;
      Eligibility:&#xD;
&#xD;
        -  Individuals between 18 and 70 years of age who are right-handed and have focal hand&#xD;
           dystonia.&#xD;
&#xD;
        -  Healthy right-handed volunteers between 18 and 60 years of age.&#xD;
&#xD;
      Design:&#xD;
&#xD;
        -  Participants will be screened with a physical exam and medical history.&#xD;
&#xD;
        -  This study includes two tests: a pilot test and a main test. The pilot test will&#xD;
           determine the frequency of TMS that will be used in the main test. Participants may be&#xD;
           in one or both tests. Each test requires a single outpatient visit that will last up to&#xD;
           5 hours.&#xD;
&#xD;
        -  Participants will have a base test to see how their muscles respond to TMS. This will&#xD;
           look at the electrical activity of the muscles. Participants will have a wire coil held&#xD;
           on their scalp. A brief electrical current will pass through the coil. It creates a&#xD;
           magnetic pulse that stimulates the brain. Researchers will test the TMS on the right and&#xD;
           left sides of the head. This will help find the spot that activates the finger muscles,&#xD;
           and see how much TMS is needed.&#xD;
&#xD;
        -  In the main test, participants will have repetitive TMS (rTMS). rTMS involves repeated&#xD;
           magnetic pulses delivered in short bursts. There will be four pulses in each burst.&#xD;
           Participants will have multiple bursts during the test. This test will look at how the&#xD;
           muscles of the hand and fingers respond to brain stimulation.&#xD;
&#xD;
        -  Treatment for focal hand dystonia will not be provided as part of this study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives:&#xD;
&#xD;
      The purpose of this protocol is to improve understanding of the pathophysiology of dystonia&#xD;
      by performing an electrophysiological study using transcranial magnetic stimulation (TMS).&#xD;
      The study may reveal new information about the role of gamma frequency oscillations in&#xD;
      cortical facilitation in dystonia patients versus healthy volunteer subjects.&#xD;
&#xD;
      The findings of this study may also help to determine if abnormal gamma frequency&#xD;
      facilitation might become a potential diagnostic tool for dystonia.&#xD;
&#xD;
      &lt;TAB&gt;&#xD;
&#xD;
      Study population:&#xD;
&#xD;
      1. We intend to study 13 healthy volunteers and 13 patients with a diagnosis of focal hand&#xD;
      dystonia. Thirteen subjects for each group are needed based on the power analysis, with an&#xD;
      additional three added to the requested accrual to account for drop-outs, yielding a maximum&#xD;
      of 16 subjects per group. Up to 15 focal hand dystonia patients and 15 healthy volunteers may&#xD;
      be involved in the pilot experiment. The pilot study will be stopped when a trend in the data&#xD;
      emerges, so the total number of subjects who participate in the pilot study may end up being&#xD;
      less than the maximum requested accrual of 15. Subjects in the pilot experiment are eligible&#xD;
      to later participate in the main experiment.&#xD;
&#xD;
      Design:&#xD;
&#xD;
      The subject will be seated with EMG surface electrodes over the First Dorsal Interosseous&#xD;
      (FDI) muscle of each hand monitoring muscle activity. The TMS coil will be placed on the&#xD;
      surface of the head and the region of motor cortex corresponding to the respective hand&#xD;
      muscle control. The baseline motor evoked potential (MEP) for the FDI muscle will be&#xD;
      determined by TMS stimulation and EMG monitoring. A pilot experiment will be performed first.&#xD;
      Conditioning stimuli, consisting of repetitive subthreshold TMS stimulation with three pulses&#xD;
      at one of eight frequencies, will be delivered. A test stimulus, consisting of a single TMS&#xD;
      pulse, will follow the conditioning stimuli at the same interval as the conditioning train,&#xD;
      but at a suprathreshold intensity in order to determine the MEP amplitude. After every 5&#xD;
      subjects the pilot data will be analyzed to check for a trend in the frequencies that lead to&#xD;
      facilitation. Once a trend emerges, the pilot study will be stopped. The four frequencies&#xD;
      with the greatest trend toward facilitation will then be selected and used in the main&#xD;
      experiment. The main experiment will be performed the same way as the pilot experiment, but&#xD;
      will use only the four frequencies found in the pilot experiment. Conditioning stimuli,&#xD;
      consisting of repetitive subthreshold TMS stimulation with three pulses at one of the&#xD;
      selected four frequencies, will be delivered. A test stimulus, consisting of a single TMS&#xD;
      pulse, will follow the conditioning stimuli at the same interval as the conditioning train,&#xD;
      but at a suprathreshold intensity in order to determine the MEP amplitude.&#xD;
&#xD;
      Outcome measures:&#xD;
&#xD;
      We will compare the MEP amplitude following TMS conditioning with the baseline MEP amplitude&#xD;
      prior to conditioning. The effect on MEP will then be compared between healthy volunteers and&#xD;
      dystonia patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>February 13, 2013</start_date>
  <completion_date type="Actual">February 19, 2019</completion_date>
  <primary_completion_date type="Actual">February 19, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Motor evoked potential following TMS conditioning versus the baseline MEP amplitude in dystonia patients and healthy subjects.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <enrollment type="Actual">30</enrollment>
  <condition>Dystonia</condition>
  <eligibility>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:&#xD;
&#xD;
          -  Confirmed diagnosis of focal hand dystonia (patients only).&#xD;
&#xD;
          -  Between age 18 and 70 years.&#xD;
&#xD;
          -  Able to give informed consent&#xD;
&#xD;
          -  Right handed&#xD;
&#xD;
          -  Agrees to not drink caffeine or alcohol for 48 hours before study session.&#xD;
&#xD;
          -  No open scalp wounds or scalp infections.&#xD;
&#xD;
        EXCLUSION CRITERIA:&#xD;
&#xD;
          -  Has used illegal drugs within the past 6 months based on history, including but not&#xD;
             limited to marijuana, cocaine, methamphetamine, etc. The intent is to exclude those&#xD;
             with drug use that may affect study results. Participants who appear to be intoxicated&#xD;
             at the time of testing will be rescheduled.&#xD;
&#xD;
          -  Has more than 7 alcoholic drinks a week in the case of a woman and 14 alcoholic drinks&#xD;
             a week in the case of a man.&#xD;
&#xD;
          -  Abnormal findings on neurologic exam (other than dystonia in patient group)&#xD;
&#xD;
          -  Has had a brain tumor, a stroke, traumatic brain injury, epilepsy or a history of&#xD;
             seizures.&#xD;
&#xD;
          -  Has major depression or any major mental disorders (axis I disorders)&#xD;
&#xD;
          -  Has a neurologic disorder other than dystonia&#xD;
&#xD;
          -  Has had a head injury where there was a loss of consciousness for more than a few&#xD;
             seconds.&#xD;
&#xD;
          -  Has a pacemaker, intracardiac lines, implanted pumps or stimulators, or has metal&#xD;
             objects inside the eye or skull. Dental fillings and dental braces are allowed.&#xD;
&#xD;
          -  Has known hearing loss.&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Taking any medication that acts as a central nervous system stimulant or that is known&#xD;
             to lower seizure threshold, including, imipramine, amitriptyline, doxepine,&#xD;
             nortriptyline, maprotiline, chlorpromazine, clozapine, foscarnet, ganciclovir,&#xD;
             ritonavir, amphetamines, cocaine, (MDMA, ecstasy), phencyclidine (PCP, angel s dust),&#xD;
             ketamine, gamma-hydroxybutyrate (GHB), alcohol, theophylline, mianserin, fluoxetine,&#xD;
             fluvoxamine, paroxetine, sertraline, citalopram, reboxetine, venlafaxine, duloxetine,&#xD;
             bupropion, mirtazapine, fluphenazine, pimozide, haloperidol, olanzapine, quetiapine,&#xD;
             aripiprazole, ziprasidone, risperidone, chloroquine, mefloquine, imipenem, penicillin,&#xD;
             ampicillin, cephalosporins, metronidazole, isoniazid, levofloxacin, cyclosporin,&#xD;
             chlorambucil, vincristine, methotrexate, cytosine arabinoside, BCNU, lithium,&#xD;
             anticholinergics, antihistamines, and sympathomimetics.&#xD;
&#xD;
          -  Has excessive daytime sleepiness as indicated by a score of 10 or higher on the&#xD;
             Epworth Sleepiness Scale.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Hallett, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institute of Neurological Disorders and Stroke (NINDS)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Brown P, Farmer SF, Halliday DM, Marsden J, Rosenberg JR. Coherent cortical and muscle discharge in cortical myoclonus. Brain. 1999 Mar;122 ( Pt 3):461-72.</citation>
    <PMID>10094255</PMID>
  </reference>
  <reference>
    <citation>Cardin JA, Carl√©n M, Meletis K, Knoblich U, Zhang F, Deisseroth K, Tsai LH, Moore CI. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature. 2009 Jun 4;459(7247):663-7. doi: 10.1038/nature08002. Epub 2009 Apr 26.</citation>
    <PMID>19396156</PMID>
  </reference>
  <reference>
    <citation>Crowell AL, Ryapolova-Webb ES, Ostrem JL, Galifianakis NB, Shimamoto S, Lim DA, Starr PA. Oscillations in sensorimotor cortex in movement disorders: an electrocorticography study. Brain. 2012 Feb;135(Pt 2):615-30. doi: 10.1093/brain/awr332. Epub 2012 Jan 16.</citation>
    <PMID>22252995</PMID>
  </reference>
  <verification_date>February 19, 2019</verification_date>
  <study_first_submitted>February 13, 2013</study_first_submitted>
  <study_first_submitted_qc>February 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2013</study_first_posted>
  <last_update_submitted>December 14, 2019</last_update_submitted>
  <last_update_submitted_qc>December 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Repetitive TMS (rTMS)</keyword>
  <keyword>Transcranial Magnetic Stimulation (TMS)</keyword>
  <keyword>Motor Cortex</keyword>
  <keyword>Focal Hand Dystonia</keyword>
  <keyword>Facilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dystonia</mesh_term>
    <mesh_term>Dystonic Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

